Kit and c-kit mutations in mastocytosis:: A short overview with special reference to novel molecular and diagnostic concepts

Kit and c-kit mutations in mastocytosis:: A short overview with special reference to novel molecular and diagnostic concepts
复制标题

DOI:
10.1159/000048179
复制
发表时间:
2002-02-01
影响因子:
2.8
通讯作者:
Arock, M
Arock, M
中科院分区:
医学3区
文献类型:
--
作者:
Féger, F;Dumas, AR;Arock, M

文献摘要

被引文献

相似文献

肥大细胞增多症是一组异质性造血疾病,其特征是肥大细胞 (MC) 在一个或多个器官中异常生长和积聚。临床症状的发生是由于化学介质的释放和/或 MC 在各种组织中的病理浸润。尽管导致肥大细胞增多症的最初事件尚未阐明,但在大量患者中已描述了编码干细胞因子 (SCF) 受体的 c-kitgene 的获得性改变,SCF 是参与 MC 生长的主要细胞因子。特别令人感兴趣的是导致组成型激活的 SCF 受体的点突变。这些突变可能与这些患者中 MC 的异常(不依赖于 SCF)增殖有关。可以设想新的治疗策略来抑制这些 c-kit 突变形式的失调的激酶活性。版权所有 (C) 2002 S. KargerAG,巴塞尔。
Mastocytosis is a heterogeneous group of hematopoietic disorders characterized by abnormal growth and accumulation of mast cells (MC) in one or more organs. Clinical symptoms occur as a result of the release of chemical mediators and/or of pathologic infiltration of MC in various tissues. Although the initial events leading to mastocytosis have not yet been unraveled, acquired alterations in the c-kitgene coding for the receptor of stem cell factor (SCF), a major cytokine involved in MC growth, have been described in a significant number of patients. Of particular interest are point mutations resulting in a constitutively activated SCF receptor. Such mutations are probably involved in the abnormal (SCF-independent) proliferation of MC in these patients. New therapeutic strategies may be envisaged to inhibit the deregulated kinase activity of these mutant forms of c-kit. Copyright (C) 2002 S. KargerAG, Basel.